OTCMKTS:HRTT

Heart Tronics Competitors

$0.02
0.00 (0.00 %)
(As of 04/19/2021 12:00 AM ET)
Add
Compare
Today's Range
$0.02
Now: $0.02
$0.02
50-Day Range
$0.02
MA: $0.43
$0.85
52-Week Range
$0.01
Now: $0.02
$1.00
Volume45 shs
Average Volume600 shs
Market CapitalizationN/A
P/E RatioN/A
Dividend YieldN/A
Beta1024.78

Competitors

Heart Tronics (OTCMKTS:HRTT) Vs. MDT, SONVY, VAR, MASI, GNGBY, and LIVN

Should you be buying HRTT stock or one of its competitors? Companies in the industry of "electromedical equipment" are considered alternatives and competitors to Heart Tronics, including Medtronic (MDT), Sonova (SONVY), Varian Medical Systems (VAR), Masimo (MASI), Getinge (GNGBY), and LivaNova (LIVN).

Medtronic (NYSE:MDT) and Heart Tronics (OTCMKTS:HRTT) are both medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, profitability, institutional ownership, earnings and risk.

Institutional & Insider Ownership

79.2% of Medtronic shares are owned by institutional investors. 0.5% of Medtronic shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company is poised for long-term growth.

Earnings & Valuation

This table compares Medtronic and Heart Tronics' revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Medtronic$28.91 billion5.98$4.79 billion$4.5927.95
Heart TronicsN/AN/AN/AN/AN/A

Medtronic has higher revenue and earnings than Heart Tronics.

Risk and Volatility

Medtronic has a beta of 0.7, suggesting that its share price is 30% less volatile than the S&P 500. Comparatively, Heart Tronics has a beta of 1024.78, suggesting that its share price is 102,378% more volatile than the S&P 500.

Analyst Ratings

This is a summary of current recommendations for Medtronic and Heart Tronics, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Medtronic031912.91
Heart Tronics0000N/A

Medtronic presently has a consensus target price of $125.3333, suggesting a potential downside of 2.32%. Given Medtronic's higher possible upside, analysts plainly believe Medtronic is more favorable than Heart Tronics.

Profitability

This table compares Medtronic and Heart Tronics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Medtronic12.69%9.71%5.30%
Heart TronicsN/AN/AN/A

Summary

Medtronic beats Heart Tronics on 9 of the 10 factors compared between the two stocks.

Heart Tronics (OTCMKTS:HRTT) and Sonova (OTCMKTS:SONVY) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, valuation, risk and profitability.

Profitability

This table compares Heart Tronics and Sonova's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Heart TronicsN/AN/AN/A
SonovaN/AN/AN/A

Analyst Ratings

This is a breakdown of recent ratings and target prices for Heart Tronics and Sonova, as reported by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Heart Tronics0000N/A
Sonova06302.33

Volatility & Risk

Heart Tronics has a beta of 1024.78, indicating that its stock price is 102,378% more volatile than the S&P 500. Comparatively, Sonova has a beta of 0.7, indicating that its stock price is 30% less volatile than the S&P 500.

Earnings & Valuation

This table compares Heart Tronics and Sonova's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Heart TronicsN/AN/AN/AN/AN/A
Sonova$2.96 billion6.35$489.96 million$1.4939.13

Sonova has higher revenue and earnings than Heart Tronics.

Institutional and Insider Ownership

1.1% of Sonova shares are owned by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Summary

Sonova beats Heart Tronics on 3 of the 4 factors compared between the two stocks.

Varian Medical Systems (NYSE:VAR) and Heart Tronics (OTCMKTS:HRTT) are both medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their dividends, earnings, analyst recommendations, institutional ownership, risk, profitability and valuation.

Profitability

This table compares Varian Medical Systems and Heart Tronics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Varian Medical Systems8.50%18.45%8.08%
Heart TronicsN/AN/AN/A

Valuation & Earnings

This table compares Varian Medical Systems and Heart Tronics' gross revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Varian Medical Systems$3.17 billion5.13$269.20 million$3.9145.29
Heart TronicsN/AN/AN/AN/AN/A

Varian Medical Systems has higher revenue and earnings than Heart Tronics.

Institutional & Insider Ownership

87.0% of Varian Medical Systems shares are held by institutional investors. 0.8% of Varian Medical Systems shares are held by company insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Analyst Recommendations

This is a summary of recent ratings and price targets for Varian Medical Systems and Heart Tronics, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Varian Medical Systems15001.83
Heart Tronics0000N/A

Varian Medical Systems presently has a consensus price target of $170.9167, indicating a potential downside of 3.48%. Given Varian Medical Systems' higher possible upside, equities analysts plainly believe Varian Medical Systems is more favorable than Heart Tronics.

Risk and Volatility

Varian Medical Systems has a beta of 1.06, meaning that its share price is 6% more volatile than the S&P 500. Comparatively, Heart Tronics has a beta of 1024.78, meaning that its share price is 102,378% more volatile than the S&P 500.

Summary

Varian Medical Systems beats Heart Tronics on 7 of the 8 factors compared between the two stocks.

Heart Tronics (OTCMKTS:HRTT) and Masimo (NASDAQ:MASI) are both medical companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, valuation, profitability, institutional ownership, risk, analyst recommendations and earnings.

Volatility & Risk

Heart Tronics has a beta of 1024.78, suggesting that its stock price is 102,378% more volatile than the S&P 500. Comparatively, Masimo has a beta of 0.87, suggesting that its stock price is 13% less volatile than the S&P 500.

Valuation & Earnings

This table compares Heart Tronics and Masimo's revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Heart TronicsN/AN/AN/AN/AN/A
Masimo$937.84 million14.28$196.22 million$3.2275.62

Masimo has higher revenue and earnings than Heart Tronics.

Profitability

This table compares Heart Tronics and Masimo's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Heart TronicsN/AN/AN/A
Masimo20.30%15.75%13.12%

Institutional and Insider Ownership

81.6% of Masimo shares are held by institutional investors. 11.5% of Masimo shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock will outperform the market over the long term.

Analyst Recommendations

This is a breakdown of current ratings for Heart Tronics and Masimo, as provided by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Heart Tronics0000N/A
Masimo02502.71

Masimo has a consensus target price of $272.20, indicating a potential upside of 11.84%. Given Masimo's higher probable upside, analysts clearly believe Masimo is more favorable than Heart Tronics.

Summary

Masimo beats Heart Tronics on 8 of the 9 factors compared between the two stocks.

Getinge (OTCMKTS:GNGBY) and Heart Tronics (OTCMKTS:HRTT) are both medical companies, but which is the better business? We will compare the two businesses based on the strength of their analyst recommendations, profitability, dividends, valuation, risk, earnings and institutional ownership.

Institutional and Insider Ownership

0.0% of Getinge shares are held by institutional investors. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

Valuation & Earnings

This table compares Getinge and Heart Tronics' gross revenue, earnings per share (EPS) and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Getinge$2.81 billion2.88$129.29 millionN/AN/A
Heart TronicsN/AN/AN/AN/AN/A

Getinge has higher revenue and earnings than Heart Tronics.

Analyst Recommendations

This is a summary of recent ratings and recommmendations for Getinge and Heart Tronics, as reported by MarketBeat.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Getinge11502.57
Heart Tronics0000N/A

Risk & Volatility

Getinge has a beta of 0.83, suggesting that its share price is 17% less volatile than the S&P 500. Comparatively, Heart Tronics has a beta of 1024.78, suggesting that its share price is 102,378% more volatile than the S&P 500.

Profitability

This table compares Getinge and Heart Tronics' net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Getinge10.51%17.30%7.90%
Heart TronicsN/AN/AN/A

Summary

Getinge beats Heart Tronics on 6 of the 7 factors compared between the two stocks.

Heart Tronics (OTCMKTS:HRTT) and LivaNova (NASDAQ:LIVN) are both medical companies, but which is the better business? We will contrast the two companies based on the strength of their valuation, profitability, risk, analyst recommendations, dividends, earnings and institutional ownership.

Profitability

This table compares Heart Tronics and LivaNova's net margins, return on equity and return on assets.

Net MarginsReturn on EquityReturn on Assets
Heart TronicsN/AN/AN/A
LivaNova-21.88%5.55%3.07%

Earnings & Valuation

This table compares Heart Tronics and LivaNova's top-line revenue, earnings per share and valuation.

Gross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Heart TronicsN/AN/AN/AN/AN/A
LivaNova$1.08 billion3.65$-155,180,000.00$3.0826.44

Heart Tronics has higher earnings, but lower revenue than LivaNova.

Insider and Institutional Ownership

89.1% of LivaNova shares are owned by institutional investors. 0.5% of LivaNova shares are owned by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

Volatility and Risk

Heart Tronics has a beta of 1024.78, indicating that its stock price is 102,378% more volatile than the S&P 500. Comparatively, LivaNova has a beta of 0.8, indicating that its stock price is 20% less volatile than the S&P 500.

Analyst Recommendations

This is a breakdown of recent ratings and recommmendations for Heart Tronics and LivaNova, as provided by MarketBeat.com.

Sell RatingsHold RatingsBuy RatingsStrong Buy RatingsRating Score
Heart Tronics0000N/A
LivaNova04202.33

LivaNova has a consensus target price of $69.3333, indicating a potential downside of 14.72%. Given LivaNova's higher possible upside, analysts clearly believe LivaNova is more favorable than Heart Tronics.

Summary

LivaNova beats Heart Tronics on 7 of the 9 factors compared between the two stocks.


Heart Tronics Competitors List

Competitor NameCompetitor BTM RankCompetitor PriceCompetitor Price ChangeCompetitor Market CapCompetitor RevenueCompetitor P/E RatioCompetitor Indicator(s)
Medtronic logo
MDT
Medtronic
2.7$128.28flat$172.93 billion$28.91 billion48.96
Sonova logo
SONVY
Sonova
0.9$58.30flat$18.87 billion$2.96 billion39.13Analyst Downgrade
Varian Medical Systems logo
VAR
Varian Medical Systems
1.3$177.07flat$16.26 billion$3.17 billion60.43
Masimo logo
MASI
Masimo
1.6$243.51flat$13.43 billion$937.84 million63.25Upcoming Earnings
News Coverage
Getinge logo
GNGBY
Getinge
0.6$31.80flat$8.05 billion$2.81 billion26.28News Coverage
LivaNova logo
LIVN
LivaNova
1.5$81.43flat$3.93 billion$1.08 billion-18.94Analyst Report
CONMED logo
CNMD
CONMED
1.6$128.08flat$3.78 billion$955.10 million-3,202.00Analyst Revision
News Coverage
InMode logo
INMD
InMode
1.5$83.99flat$2.75 billion$156.36 million60.42
Outset Medical logo
OM
Outset Medical
1.1$55.50flat$2.31 billionN/A0.00Analyst Report
BioLife Solutions logo
BLFS
BioLife Solutions
2.1$31.51flat$1.09 billion$27.37 million-43.16Insider Selling
Increase in Short Interest
NTUS
Natus Medical
1.1$26.98flat$950.67 million$495.52 million-49.05
SMLR
Semler Scientific
1.2$106.88flat$738.87 million$32.77 million75.26
AxoGen logo
AXGN
AxoGen
1.7$18.34flat$725.74 million$106.71 million-29.11News Coverage
TransMedics Group logo
TMDX
TransMedics Group
1.6$25.04flat$711.89 million$23.60 million-17.89Increase in Short Interest
ViewRay logo
VRAY
ViewRay
1.5$3.94flat$670.54 million$87.78 million-4.43News Coverage
Gap Up
Stereotaxis logo
STXS
Stereotaxis
0.6$7.68flat$603.75 million$28.90 million-69.82
Zynex logo
ZYXI
Zynex
1.8$14.82flat$540.60 million$45.47 million44.91News Coverage
Cutera logo
CUTR
Cutera
1.5$27.50flat$515.89 million$181.71 million-15.19News Coverage
Edap Tms logo
EDAP
Edap Tms
1.3$8.33flat$248.00 million$50.23 million-138.83Increase in Short Interest
Gap Down
Second Sight Medical Products logo
EYES
Second Sight Medical Products
0.8$7.34flat$194.80 million$3.38 million-3.84Decrease in Short Interest
FONR
FONAR
1.1$17.62flat$117.38 million$85.69 million16.62
IRIDEX logo
IRIX
IRIDEX
0.9$7.07flat$115.17 million$43.45 million-12.85Gap Up
BioSig Technologies logo
BSGM
BioSig Technologies
0.5$3.43flat$109.04 millionN/A0.00
ENDRA Life Sciences logo
NDRA
ENDRA Life Sciences
0.6$2.20flat$95.26 million$10,000.00-1.20Analyst Downgrade
Gap Up
Soleno Therapeutics logo
SLNO
Soleno Therapeutics
1.9$1.10flat$94.07 millionN/A-1.45Analyst Downgrade
Increase in Short Interest
electroCore logo
ECOR
electroCore
1.4$1.74flat$89.68 million$2.39 million-2.20Gap Down
Electromed logo
ELMD
Electromed
1.8$10.10flat$86.61 million$32.47 million24.05News Coverage
Helius Medical Technologies logo
HSDT
Helius Medical Technologies
1.3$17.10flat$39.98 million$1.50 million-0.98
Fc Global Realty logo
FCRE
Fc Global Realty
0.5$0.10flat$38.87 million$40,000.000.00Gap Up
CHF Solutions logo
CHFS
CHF Solutions
1.7$5.03flat$32.00 million$5.51 million-0.10Increase in Short Interest
News Coverage
ReShape Lifesciences logo
RSLS
ReShape Lifesciences
0.6$3.95flat$27.75 million$15.09 million0.00Gap Up
Viveve Medical logo
VIVE
Viveve Medical
0.9$2.63flat$26.48 million$6.57 million-0.01
PEYE
Precision Optics
0.4$1.62flat$22.55 million$9.92 million-16.20
Vaso logo
VASO
Vaso
0.9$0.09flat$16.46 million$75.75 million4.45Gap Down
Star Equity logo
STRR
Star Equity
0.1$2.76flat$13.09 million$114.18 million-0.88
Micron Solutions logo
MICR
Micron Solutions
0.1$3.13flat$11.73 million$17.50 million22.32Increase in Short Interest
GTHP
Guided Therapeutics
0.3$0.72flat$10.54 million$40,000.00-3.00
NIMU
Non-Invasive Monitoring Systems
0.5$0.03flat$2.49 millionN/A0.00Upcoming Earnings
RSLSD
ReShape Lifesciences
0.4N/AN/A$1.94 million$610,000.000.00High Trading Volume
MAGAA
Magna-Lab
0.7$1.24flat$1.46 millionN/A6.89
Nexeon MedSystems logo
NXNN
Nexeon MedSystems
0.7$0.55flat$1.12 millionN/A0.00
ARDMQ
Aradigm
0.0$0.05flat$764,000.00N/A0.00
IMRIS logo
IMRSQ
IMRIS
0.5$0.00flat$468,000.00N/A0.00Gap Up
SCIE
SpectraScience
0.5$0.00flat$265,000.00N/A0.00
Echo Therapeutics logo
ECTE
Echo Therapeutics
0.5$0.02flat$234,000.00N/A0.00
ULGX
Urologix
0.6$0.01flat$111,000.00N/A0.00Gap Down
AKSY
Aksys
0.0$0.05flat$0.00N/A0.00Gap Down
Escalon Medical logo
ESMC
Escalon Medical
0.5$0.40flat$0.00$9.40 million-6.67
IVVI
Ivivi Technologies
0.0$0.00flat$0.00N/A0.00High Trading Volume
NWCI
NewCardio
0.5$0.00flat$0.00N/A0.00Gap Up
This page was last updated on 4/20/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security. Learn more.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.